Insider · CIK 0001222790

SCANNON PATRICK J MD PHD

Reports to the SEC for 2 companies · BERKELEY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001222790

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-23	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+26.5K sh	—	—	26,500
2024-05-09	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-06-12	FLNAFILANA THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$0.95	+$950	1,000
2023-06-12	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	$0.95	−$950	9,000
2023-05-04	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	$22.34	+$447K	20,000
2020-12-11	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2019-12-13	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2018-09-14	FLNAFILANA THERAPEUTICS, INC. · Stock Options(1)A Award	Director	AAward	+10K sh	$0.95	+$9,500	107,400
2017-12-06	FLNAFILANA THERAPEUTICS, INC. · Non-Qualifying Stock Options (1)A Award	Director	AAward	+20K sh	$4.09	+$81.8K	107,204
2017-05-04	FLNAFILANA THERAPEUTICS, INC. · Non-Qualifying Stock Options (1)A Award	Director	AAward	+50K sh	$0.78	+$39K	679,128
2016-12-21	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−3,230 sh	$5.75	−$18.6K	8,217
2016-05-12	FLNAFILANA THERAPEUTICS, INC. · Non-Qualifying Stock Options (1)A Award	Director	AAward	+50K sh	$2.38	+$119K	629,128
2016-03-22	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−14.8K sh	$0.78	−$11.6K	228,942
2016-03-18	XOMA Royalty CorpM Exercise/Conversion	Exec. VP & CSO, Exec. VP & CSO	MExercise/Conversion	+9,500 sh	—	—	243,727
2016-03-18	XOMA Royalty CorpRestricted Stock UnitsM Exercise/Conversion	Exec. VP & CSO, Exec. VP & CSO	MExercise/Conversion	−9,500 sh	—	—	0
2016-02-25	XOMA Royalty CorpA Award	Exec. VP & CSO, Exec. VP & CSO	AAward	+140K sh	—	—	234,227
2016-02-01	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−8,000 sh	$1.01	−$8,080	94,227
2015-12-31	XOMA Royalty CorpJ Other	Exec. VP & CSO, Exec. VP & CSO	JOther	+8,721 sh	$1.38	+$12K	33,801
2015-12-28	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−8,000 sh	$1.37	−$10.9K	102,227
2015-11-23	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−8,000 sh	$1.35	−$10.8K	110,227
2015-10-26	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−8,000 sh	$1.04	−$8,357.6	118,227
2015-08-14	XOMA Royalty CorpD Disposition to Issuer	Exec. VP & CSO, Exec. VP & CSO	DDisposition to Issuer	−6,157 sh	$0.83	−$5,131.86	109,963
2015-08-14	XOMA Royalty CorpM Exercise/Conversion	Exec. VP & CSO, Exec. VP & CSO	MExercise/Conversion	+16.3K sh	—	—	126,227
2015-08-14	XOMA Royalty CorpRestricted Stock UnitsM Exercise/Conversion	Exec. VP & CSO, Exec. VP & CSO	MExercise/Conversion	−16.3K sh	—	—	38,917
2015-05-14	FLNAFILANA THERAPEUTICS, INC. · Non-Qualifying Stock Options (1)A Award	Director	AAward	+50K sh	$2.23	+$112K	579,128
2015-03-18	XOMA Royalty CorpM Exercise/Conversion	Exec. VP & CSO, Exec. VP & CSO	MExercise/Conversion	+9,500 sh	—	—	124,786
2015-03-18	XOMA Royalty CorpD Disposition to Issuer	Exec. VP & CSO, Exec. VP & CSO	DDisposition to Issuer	−3,433 sh	$4.01	−$13.8K	121,353
2015-03-18	XOMA Royalty CorpD Disposition to Issuer	Exec. VP & CSO, Exec. VP & CSO	DDisposition to Issuer	−5,233 sh	$4.01	−$21K	116,120
2015-03-18	XOMA Royalty CorpRestricted Stock UnitsM Exercise/Conversion	Exec. VP & CSO, Exec. VP & CSO	MExercise/Conversion	−9,500 sh	—	—	9,500
2015-02-26	XOMA Royalty CorpA Award	Exec. VP & CSO, Exec. VP & CSO	AAward	+38.9K sh	—	—	115,286
2015-02-26	XOMA Royalty CorpNon-Qualified Share Option (right to buy)A Award	Exec. VP & CSO, Exec. VP & CSO	AAward	+52.1K sh	$3.83	+$200K	52,146
2015-02-02	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−5,000 sh	$3.52	−$17.6K	76,346
2015-01-02	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−5,000 sh	$3.55	−$17.8K	81,346
2014-12-31	XOMA Royalty CorpJ Other	Exec. VP & CSO, Exec. VP & CSO	JOther	+3,001 sh	$3.83	+$11.5K	25,080
2014-12-01	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−5,000 sh	$5.51	−$27.6K	86,346
2014-11-13	XOMA Royalty CorpM Exercise/Conversion	Exec. VP & CSO, Exec. VP & CSO	MExercise/Conversion	+22.7K sh	—	—	99,591
2014-11-13	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−8,245 sh	$3.89	−$32.1K	91,346
2014-11-13	XOMA Royalty CorpRestricted Stock UnitsM Exercise/Conversion	Exec. VP & CSO, Exec. VP & CSO	MExercise/Conversion	−22.7K sh	—	—	6,388
2014-11-03	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−5,000 sh	$4.33	−$21.7K	76,939
2014-10-01	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−5,000 sh	$4.09	−$20.4K	81,939
2014-09-02	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−5,000 sh	$4.31	−$21.6K	86,939
2014-08-15	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−5,871 sh	$4.31	−$25.3K	91,939
2014-08-14	XOMA Royalty CorpM Exercise/Conversion	Exec. VP & CSO, Exec. VP & CSO	MExercise/Conversion	+16.3K sh	—	—	97,810
2014-08-14	XOMA Royalty CorpRestricted Stock UnitsM Exercise/Conversion	Exec. VP & CSO, Exec. VP & CSO	MExercise/Conversion	−16.3K sh	—	—	29,040
2014-08-01	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−5,000 sh	$3.83	−$19.2K	81,546
2014-07-01	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−5,000 sh	$4.68	−$23.4K	86,546
2014-03-18	XOMA Royalty CorpM Exercise/Conversion	Exec. VP & CSO, Exec. VP & CSO	MExercise/Conversion	+9,500 sh	—	—	94,965
2014-03-18	XOMA Royalty CorpS Sale	Exec. VP & CSO, Exec. VP & CSO	SSale	−3,419 sh	$6.32	−$21.6K	91,546
2014-03-18	XOMA Royalty CorpRestricted Stock UnitsM Exercise/Conversion	Exec. VP & CSO, Exec. VP & CSO	MExercise/Conversion	−9,500 sh	—	—	19,000
2014-02-27	XOMA Royalty CorpA Award	Exec. VP & CSO, Exec. VP & CSO	AAward	+43.4K sh	—	—	85,465

Recent filings

Accepted (ET)
Jul 164
SCANNON PATRICK J MD PHD0001437749-25-022829
SEC(opens sec.gov)
May 134
SCANNON PATRICK J MD PHD0001437749-24-016242
SEC(opens sec.gov)
Jun 124
SCANNON PATRICK J MD PHD0001069530-23-000037
SEC(opens sec.gov)
May 84
SCANNON PATRICK J MD PHD0001069530-23-000031
SEC(opens sec.gov)
Dec 144
SCANNON PATRICK J MD PHD0001069530-20-000077
SEC(opens sec.gov)
Dec 164
SCANNON PATRICK J MD PHD0001069530-19-000057
SEC(opens sec.gov)
Sep 184
SCANNON PATRICK J MD PHD0001069530-18-000047
SEC(opens sec.gov)
Dec 84
SCANNON PATRICK J MD PHD0001069530-17-000044
SEC(opens sec.gov)
May 54
PAIN THERAPEUTICS INC0001573723-17-000005
SEC(opens sec.gov)
Dec 234
XOMA Corp0000791908-16-000180
SEC(opens sec.gov)
May 184
PAIN THERAPEUTICS INC0001573723-16-000019
SEC(opens sec.gov)
Mar 224
XOMA Corp0000791908-16-000133
SEC(opens sec.gov)
Feb 294
XOMA Corp0000791908-16-000123
SEC(opens sec.gov)
Feb 165
XOMA Corp0000791908-16-000113
SEC(opens sec.gov)
Feb 34
XOMA Corp0000791908-16-000109
SEC(opens sec.gov)
Dec 304
XOMA Corp0000791908-15-000107
SEC(opens sec.gov)
Nov 254
XOMA Corp0000791908-15-000103
SEC(opens sec.gov)

Companies

Address

C/O XOMA LTD. 2910 SEVENTH STREET

BERKELEY, CA, 94710